RARE-09. CYSTIC GLIOBLASTOMA PRESENTATION AS A BENEFICIAL PROGNOSTIC INDICATOR FOR OVERALL SURVIVAL

Glioblastoma (GBM) is the most aggressive primary brain tumor with a median overall survival of 15 months with standard-of-care treatment. GBM patients sometimes present with a cystic component, which can be identified through magnetic resonance imaging (MRI). Previous studies suggest that cysts occ...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Curtin, Lee, Whitmire, Paula, Rickertsen, Cassandra, Canoll, Peter D, Mrugala, Maciej, Swanson, Kristin, Hu, Leland
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Rare Tumors
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847682/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.932
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia